Biodegradable poly(CL-co-TOSUO)/curcumin membrane: Biocompatibility and IL-6 suppression in atherosclerosis-relevant macrophage inflammation
Journal of Biomaterials Applications · 2026
DOI: 10.1177/08853282251369236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2026. Verfasst von Dongping Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Binhaiwan Central Hospital of Dongguan, Dongguan, China. Hauptthemen laut MEDLINE: Curcumin, Interleukin-6, Atherosclerosis, Polyesters. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Atherosclerotic plaque instability, driven by macrophage-derived foam cells and exacerbated by interleukin-6 (IL-6), necessitates localized anti-inflammatory strategies. To address this, we developed curcumin-loaded poly(ε-caprolactone-co-4-ethylenediol ketal-ε-caprolactone) (PCT) membranes via electrospinning, characterizing their sustained drug release, biodegradability, and morphology through SEM. Comprehensive in vitro assessments included endothelial/macrophage viability assays, hemolysis testing, foam cell modeling using Ox-LDL (80 μg/mL for 48 h, optimized for IL-6 upregulation), and inflammatory cytokine quantification (IL-6/TNF-α/IFN-γ) via RT-qPCR. Subcutaneous implantation in rats enabled histological evaluation via HE staining and IL-6 immunohistochemistry. Our results demonstrated that curcumin-PCT membranes exhibited sustained drug release and biodegradability while maintaining exceptional hemocompatibility and endothelial safety. The membrane extracts significantly inhibited macrophage activity and downregulated pro-inflammatory cytokines, with IL-6 suppression being the most pronounced. In vivo analyses corroborated these findings, showing reduced leukocyte infiltration and attenuated IL-6 expression compared to poly(ε-caprolactone) controls. Collectively, this study establishes curcumin-loaded PCT as a biocompatible platform with targeted efficacy against macrophage-driven vascular inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Binhaiwan Central Hospital of Dongguan, Dongguan, China.
- GD Functional Biomaterials Engineering Technology Research Center, Guangzhou Key Laboratory of Flexible Electronic Materials and Wearable Devices, School of Materials Science and Engineering, Sun Yat-sen University, Gua…
- Cardiovascular Department, Binhaiwan Central Hospital of Dongguan, Dongguan, China.
ORCID-Profile: Dongping Chen, Jianmin Xiao
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Chen, D., Liu, Q., Yang, L., Chen, C., Zhou, J., & Xiao, J. (2026). Biodegradable poly(CL-co-TOSUO)/curcumin membrane: Biocompatibility and IL-6 suppression in atherosclerosis-relevant macrophage inflammation. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251369236
Vancouver
Chen D, Liu Q, Yang L, Chen C, Zhou J, Xiao J. Biodegradable poly(CL-co-TOSUO)/curcumin membrane: Biocompatibility and IL-6 suppression in atherosclerosis-relevant macrophage inflammation. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282251369236
BibTeX
@article{Chen2026,
author = {Chen, Dongping and Liu, Qingfa and Yang, Lu and Chen, Can and Zhou, Jing and Xiao, Jianmin},
title = {Biodegradable poly(CL-co-TOSUO)/curcumin membrane: Biocompatibility and IL-6 suppression in atherosclerosis-relevant macrophage inflammation},
journal = {Journal of Biomaterials Applications},
year = {2026},
doi = {10.1177/08853282251369236}
}
EUVIMED